DFE Pharma, Harro Höfliger, and Sterling Partner to Provide Formulation Services for Respiratory Products

Published on: 

DFE Pharma, Harro Höfliger, and Sterling have announced a partnership called Inhalation Together to provide formulation services for respiratory products.

Excipients solution provider DFE Pharma, equipment supplier Harro Höfliger, and API manufacturer Sterling announced on March 24, 2022 a unique partnership with the establishment of Inhalation Together (INTO) in the field of dry powder inhalation (DPI).

This initiative will provide R&D services to pharmaceutical companies in the respiratory field, improving formulation development to be simpler, faster, and easier to manage. The combination of INTO’s suite of services and each of the companies’ field of expertise allows for a stronger and more focused progression for development.

Developing a DPI formulation requires a strong interdependency between process, powder, device, and patient. To address this complexity, INTO provides consultancy services, such as solid-state characterization and sono-crystallization of APIs and studies to optimize formulation, blending, and filling.


I am very excited about the INTO initiative because it increases speed to market and reduces the complexity of formulation and process development,” said Martti Hedman, CEO of DFE Pharma, in the press release. “The three companies have a very good understanding of the critical aspects of development and manufacture of DPI products, therefore, adding significant value to our customers.”

Source: DFE Pharma